Mayo Clinic partnered with South Korea-based AI company Vuno to develop AI and machine learning for more precise diagnosis, prognosis and treatment stratification in cancer, according to an April 25 press release.
The collaborative agreement will combine Mayo Clinic’s AI research, clinical expertise and resources with Vuno’s AI research and development capabilities to create a broad spectrum of predictive and prognostic biomarkers.
The biomarkers aim to help make therapeutic decisions, which will improve the quality of cancer patient care.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
